Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cross Country Healthcare Inc Announces Agreement to Sell Clinical Trial Services Business to Icon PLC


Monday, 4 Feb 2013 06:30am EST 

Cross Country Healthcare Inc announced that it has entered into an agreement to sell its clinical trial services business to ICON plc for $52 million, plus an earn-out of up to $3.75 million related to certain performance-based milestones. This transaction is expected to be completed within the next 30 days. Cross Country Healthcare intends to use a portion of the net proceeds from this transaction to retire all of its outstanding bank debt. 

Company Quote

8.08
-0.36 -4.27%
1:46pm EDT